<DOC>
	<DOCNO>NCT02644395</DOCNO>
	<brief_summary>Background : Calcineurin inhibitor ( CNIs ) commonly use immunosuppressive drug prevent rejection kidney transplantation . However , efficacy prevent rejection come cost important side-effects . Among common side-effects hypertension . Hypertension kidney transplantation clinically relevant , increase risk cardiovascular disease associate increase graft loss recipient mortality . The mechanism CNI-induced hypertension incompletely understood , therefore , treatment currently empiric . These investigator recently show CNIs cause salt-sensitive hypertension activate sodium transporter kidney , namely thiazide-sensitive sodium chloride cotransporter . Hypothesis : The investigator hypothesize thiazide diuretic non-inferior calcium channel blocker ( CCBs ) ( currently usually treatment choice ) treatment CNI-induced hypertension . Objective : To compare blood pressure response thiazide diuretic CCBs patient CNI-induced hypertension . Study design : Single-center , randomize cross-over trial . Study population : Kidney transplant recipient good functioning allograft ( eGFR &gt; 30 ml/min ) hypertensive ( daytime systolic blood pressure &gt; 140 mm Hg ) proteinuria ( &lt; 1 g/day ) . Intervention : Patients randomize receive chlorthalidone ( 12.5 mg daily , need titrated 25 mg daily ) amlodipine ( 5 mg daily , need titrated 10 mg daily ) . Main study parameters/endpoints : 24-hour blood pressure record . Nature extent burden risk associate participation , benefit group relatedness : Both drug long register treatment hypertension . The side-effect profile drug consider equal . The burden study patient blood pressure measurement use 30-minute automate blood pressure measurement 24-hour ambulatory blood pressure measurement .</brief_summary>
	<brief_title>Thiazide Diuretics Hypertension Kidney Transplant Recipients Using Tacrolimus</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sodium Chloride Symporter Inhibitors</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Kidney transplant recipient use tacrolimus Average daytime SBP &gt; 140 mm Hg ( ABPM ) eGFR &gt; 30 ml/min ( MDRD ) Use glucocorticoid , cotrimoxazole , diuretic Pregnancy Serum sodium &lt; 136 , serum potassium &lt; 3.5 Proteinuria &gt; 1 g/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>